Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-33 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dermatitis, Atopic 2 D003876 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4650487